collaborating with pharma · collaborating with pharma by darren spevick chair, emig digital health...
TRANSCRIPT
Collaborating with Pharma
By Darren Spevick Chair, EMIG Digital Health Managing Partner – Eventum PartnersJune 2019
Agenda
Introduction to
Darren Spevick and Eventum Partners
EMIG Digital Health Special Interest Group
Collaborating with the pharmaceutical industry
Eventum Partners
Darren Spevick – 20 years recruitment experience in pharma, life sciences, digital health
Set up Eventum Partners in 2013
Focus on senior level interim and permanent appointments
We work with providers of healthcare products (pharma / med tech), health technology and health services
EMIG Digital Health
EMIG – Ethical Medicines Industry Group
Represents c200 UK SME Pharma companies
Alexion, Allergan, Amgen, Astellas, Baxter, Celgene, Gilead, Sandoz, Takeda, Teva…
Digital Health SIG set up 2016
McLaren Applied Technologies, Oviva, Aparito, Draper & Dash, Benevolent AI, Medisafe, Cognitant
Imperial College Health Partners, MHRA, Deloitte, Digitalhealth.london, NHS Digital
Pharma already collaborates
Pharma
CRO
NHS
Academia
Software
Data
Charities
Patient
Groups
Service provides
Why collaborate?
Pharma
TechnologyServices
Patient
Why collaborate?
Pharma Tech
Pharma and Technology
Challenges of collaboration
SME pharma are interested - limited resource
Big pharma – have the resource, are they really committed?
Demonstrate the value proposition of the technology =
does it deliver cost savings?
patient benefits?
increased sales?
Who is going to pay for the technology?
Regulations?
Legal / commercial agreements?
Examples of collaboration
Recent collaborations Swedish startup Pilloxa announces collaboration with
Novartis division – Sandoz Nordics AstraZeneca and BenevolentAI have begun a long term
collaboration AI and machine learning for the discovery and development of new treatments
Owlstone Medical has announced a strategic collaboration with Actelion Pharmaceuticals to discover and validate a breath-based test to help facilitate the early diagnosis of pulmonary hypertension
Eli Lilly has collaborated with Atomwise for a multiyear discovery agreement to use its AI to generate new leads for up to 10 of its drug targets, at up to $1 million a pop
Summary
Collaborations are happening
Pharma industry is engaging
Collaborations are the key for digital health / therapeutics to transform the way healthcare is managed and delivered
Thank you
Let’s collaborate
T | 0044 203 670 1111M | 0044 7974 369111E | [email protected] | eventumpartners.com
| https://www.linkedin.com/company/eventum-partners